Patents by Inventor Jenna Goldberg

Jenna Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating multiple myeloma
    Patent number: 11952426
    Abstract: Methods of treating cancers using a BCMAxCD3 bispecific antibody are described.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: April 9, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin
  • APPROVED PRODUCTS FOR THE TREATMENT OF MULTIPLE MYELOMA
    Publication number: 20240076376
    Abstract: Described herein are approved products and methods of using approved products for treating relapsed or refractory multiple myeloma in a patient. Also described herein are methods of selling or offering for sale an approved product.
    Type: Application
    Filed: August 21, 2023
    Publication date: March 7, 2024
    Inventors: Jenna Goldberg, Arnob Banerjee
  • METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF GPRC5DXCD3 BISPECIFIC ANTIBODIES
    Publication number: 20230295292
    Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics. In particular, methods are disclosed of using a GPRC5DxCD3 bispecific antibody, an anti-CD38 antibody and/or pomalidomide to treat cancers.
    Type: Application
    Filed: November 2, 2022
    Publication date: September 21, 2023
    Inventors: Jenna Goldberg, Shun Xin Wang Lin, Thomas J. Prior, Raluca Verona, Brendan Weiss
  • METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF BCMAXCD3 BISPECIFIC ANTIBODIES
    Publication number: 20230272102
    Abstract: Disclosed are methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodies. In particular, methods are disclosed of using a BCMAxCD3 bispecific antibody, an anti-CD38 antibody and/or pomalidomide to treat cancers, particularly relapsed or refractory multiple myeloma.
    Type: Application
    Filed: November 2, 2022
    Publication date: August 31, 2023
    Inventors: Jenna Goldberg, Jagoda Jasielec, Raluca Verona, Brendan Weiss
  • METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY
    Publication number: 20230061503
    Abstract: The present disclosure relates to methods of early identification and detection of neurotoxicity associated with the administration of chimeric antigen receptor (CAR) T cell therapy and mitigation strategies to reduce the occurrence and/or severity of treatment associated neurotoxicity.
    Type: Application
    Filed: May 10, 2022
    Publication date: March 2, 2023
    Inventors: Muhammad S. AKRAM, Kevin C. De Braganca, Jenna Goldberg, Carolyn Chang Jackson, Erin C. Lee, Nikoletta Lendvai, Maria Marquez de Mondelo, Yunsi Olyslager, Jun Qiu, Enrique Zudaire Ubani, Jean Xu
  • METHODS AND COMPOSITIONS FOR MONITORING THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
    Publication number: 20220373550
    Abstract: Methods of monitoring progression of multiple myeloma or plasmacytoma, particularly relapsed or refractory multiple myeloma, are described. Also described are methods of treating or determining response to a treatment for multiple myeloma or plasmacytoma in a subject.
    Type: Application
    Filed: May 11, 2022
    Publication date: November 24, 2022
    Inventors: Kodandaram Pillarisetti, Suzette Girgis, Jenna Goldberg, Shun Xin Wang Lin
  • METHODS FOR TREATING MULTIPLE MYELOMA
    Publication number: 20220177584
    Abstract: Methods of treating a hematological malignancy using a GPRC5D×CD3 bispecific antibody are described. The hematological malignancy can be a relapsed or refractory multiple myeloma, and the GPRC5D×CD3 bispecific antibody can be talquetamab.
    Type: Application
    Filed: September 16, 2021
    Publication date: June 9, 2022
    Inventors: Suzette Girgis, Jenna Goldberg, Brandi Hilder, Xuewen Ma, Jeffery Russell, Raluca Verona, Shiyi Yang, Kodandaram Pillarisetti
  • Methods for Treating Multiple Myeloma
    Publication number: 20220041742
    Abstract: Methods of treating cancers using a BCMA×CD3 bispecific antibody are described.
    Type: Application
    Filed: May 11, 2021
    Publication date: February 10, 2022
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin